COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis
- PMID: 33772772
- PMCID: PMC8250119
- DOI: 10.1111/eci.13559
COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis
Abstract
Background: COVID-19 is an infectious disease caused by SARS-CoV-2 associated with haematological manifestations (thrombolytic events).
Aims: Considering the high prevalence of the thrombotic scenarios associated with COVID-19, the aim of this study was to perform a systematic review of the available literature, concerning the relation of COVID-19 and the thrombotic events, and identify prognostic factors for these events.
Materials & methods: PubMed, Web of Science and Scopus databases were searched. Independent reviewers conducted all flow diagram steps. For qualitative analysis, Oxford level of evidence and Newcastle-Ottawa scale were used in the eligible articles. For the prognostic factors, a meta-analysis was conducted to age, number of neutrophils and platelets, and levels of ferritin, C-reactive protein, lactate dehydrogenase and D-dimer. Publication bias was accessed by funnel plot and by trim-and-fill test. Trim-and-fill test was also applied to evaluate meta-analysis bias.
Results: Twenty articles were included in the qualitative analysis, and 6 articles were included in the meta-analysis. Case-control studies showed bias related to exposure, and the main bias in cohort studies were related to selection and outcome. All articles received score 4 for the level of evidence. Hypertension and diabetes were the comorbidities more frequently associated with thrombolytic events. Significant results were found regarding D-dimer (P < .0001) and age (P = .0202) for thrombotic events in patients diagnosed with COVID-19.
Conclusion: Patients older than 60 years, with hypertension, diabetes and D-Dimer values above 3.17 µg/mL, can be considered prognostic factors for developing thrombotic events due to COVID-19.
Keywords: COVID-19; D-dimer; SARS-CoV-2; meta-analysis; prognostic factors; systematic review; thrombosis.
© 2021 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Conflict of interest statement
There is no conflict of interest involving any author in the present study.
Figures




Similar articles
-
Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.Thromb Res. 2020 Dec;196:209-212. doi: 10.1016/j.thromres.2020.09.004. Epub 2020 Sep 3. Thromb Res. 2020. PMID: 32911392 Free PMC article.
-
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):597-604. doi: 10.1016/j.jvsv.2020.09.010. Epub 2020 Oct 8. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33039545 Free PMC article.
-
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.Intern Emerg Med. 2021 Aug;16(5):1231-1237. doi: 10.1007/s11739-020-02621-8. Epub 2021 Jul 4. Intern Emerg Med. 2021. PMID: 34218413 Free PMC article.
-
Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies.Ther Adv Cardiovasc Dis. 2022 Jan-Dec;16:17539447221105013. doi: 10.1177/17539447221105013. Ther Adv Cardiovasc Dis. 2022. PMID: 35762736 Free PMC article.
-
D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis.Front Public Health. 2020 Aug 4;8:432. doi: 10.3389/fpubh.2020.00432. eCollection 2020. Front Public Health. 2020. PMID: 32903841 Free PMC article.
Cited by
-
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.Thromb J. 2022 Sep 26;20(1):55. doi: 10.1186/s12959-022-00411-0. Thromb J. 2022. PMID: 36163073 Free PMC article.
-
Revision of Clinical Pre-Test Probability Scores in Hospitalized Patients with Pulmonary Embolism and SARS-CoV-2 Infection.Rev Cardiovasc Med. 2023 Jan 10;24(1):18. doi: 10.31083/j.rcm2401018. eCollection 2023 Jan. Rev Cardiovasc Med. 2023. PMID: 39076868 Free PMC article.
-
The bimodal "rise and fall" ACS curve overlapping COVID-19 pandemic peaks.Am J Cardiovasc Dis. 2021 Jun 15;11(3):295-299. eCollection 2021. Am J Cardiovasc Dis. 2021. PMID: 34322300 Free PMC article.
-
Unusual Presentation of a Severe COVID-19 Case With Axillary Artery Thrombosis.Cureus. 2021 May 15;13(5):e15036. doi: 10.7759/cureus.15036. Cureus. 2021. PMID: 34150387 Free PMC article.
-
Ludwig's angina in a COVID positive patient-An atypical case report.Spec Care Dentist. 2022 Jan;42(1):99-102. doi: 10.1111/scd.12643. Epub 2021 Aug 26. Spec Care Dentist. 2022. PMID: 34448220 Free PMC article.
References
-
- World Health Organization WHO . Director‐General's Statement on IHR Emergency Committee on Novel Coronavirus (2019‐nCoV) [Internet]. Genebra; 2020:1‐4. https://www.who.int/dg/speeches/detail/who‐director‐general‐s‐statement‐.... Accessed February 19, 2021.
-
- World Health Organization WHO . Clinical management of severe acute respiratory infection (SARI) when COVID‐19 disease is suspected. Interim guidance. Pediatria i Medycyna Rodzinna. 2020;16:9‐26.
Publication types
MeSH terms
Substances
Grants and funding
- 88887.468865/2019-00/Coordination for the Improvement of Higher Education Personnel (CAPES)
- 88887.571226/2020-00/Coordination for the Improvement of Higher Education Personnel (CAPES)
- 2018/18440-0/The São Paulo Research Foundation (FAPESP)
- 2020/07110-0/The São Paulo Research Foundation (FAPESP)
- 2019/08375-0/The São Paulo Research Foundation (FAPESP)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous